Erbitux
information and resources from the National Cancer Institute
NCI Thesaurus | Erbitux
(Other name for: cetuximab)NCI Thesaurus | Erbitux
(Other name for: cetuximab)
|
|
|
|
news articles
Erbitux® Plus Camptosar® Effective in Patients with Colorectal ... Mar 29, 2006
Cancer Consultants (press release), According to article published in the British Journal of Cancer, the treatment combination consisting of Erbitux® (cetuximab) and Camptosar® (irinotecan ...
FDA OKs Erbitux for Head & Neck Cancer Mar 2, 2006
FOX News By Miranda Hitti. The FDA has approved Erbitux, a drug to help treat cancer of the head and neck. Erbitux is designed for use in ...
FDA approves Erbitux for head, neck cancer Mar 2, 2006
Reuters.uk, WASHINGTON/NEW YORK (Reuters) - US regulators on Wednesday approved ImClone Systems Inc.'s colon cancer drug Erbitux to treat head and neck cancer in cases ...
Erbitux OK’d for Other Cancer Mar 2, 2006
Red Herring, ImClone Systems and Bristol-Myers Squibb said Thursday that US regulators have approved their cancer drug Erbitux for another type of head and neck cancer ...
CORRECTED - UPDATE 2-US FDA approves Erbitux for head and neck ... Mar 1, 2006
Reuters In WASHINGTON/NEW YORK story headlined "UPDATE 2-US FDA approves Erbitux for head and neck cancer," please read in 11th paragraph ... ...
UPDATE 2-US FDA approves Erbitux for head and neck cancer Mar 1, 2006
Reuters NEW YORK, March 1 (Reuters) - US regulators on Wednesday approved ImClone Systems Inc.'s (IMCL.O: Quote, Profile, Research) colon cancer drug Erbitux to treat ...
Erbitux Gets Added Approval Mar 1, 2006
TheStreet.com Food and Drug Administration on Wednesday approved a new use for ImClone Systems' (IMCL:Nasdaq - commentary - research - Cramer's Take) Erbitux, endorsing the ...
CORRECTED - UPDATE 2-US FDA approves Erbitux for head and neck ... Mar 2, 2006
Reuters In the March 1 WASHINGTON/NEW YORK story headlined "CORRECTED - UPDATE 2-US FDA approves Erbitux for head and neck cancer," please read at the beginning of the ...
Update 2: Erbitux Approved for Head, Neck Cancer Mar 1, 2006
Forbes Federal regulators on Wednesday approved Erbitux as the first new drug to treat head and neck cancer since the 1950s. ... Erbitux is made by ImClone Systems Inc. ...
Erbitux Approved for Head, Neck Cancer Mar 1, 2006
Washington Post, WASHINGTON -- Federal regulators on Wednesday approved Erbitux as the first new drug to treat head and neck cancer since the 1950s. ...
Erbitux given FDA greenlight for head, neck cancer Mar 2, 2006
Xinhua, 3 -- The US Food and Drug Administration has approved colon cancer drug Erbitux to treat head and neck cancer after results of a large clinical trial showed ...
ImClone Outlook Boosted By New Erbitux-Use Approval Mar 2, 2006
Forbes ...target on ImClone Systems to $45 from $42 on higher long-term growth prospects related to the US Food and Drug Administration's approval of Erbitux use for ...
FDA approves new cancer drug Erbitux Mar 2, 2006
Monsters and Critics.com, The FDA approved Erbitux (cetuximab) for use in combination with radiation therapy to treat patients with squamous cell cancer of the head and neck that can ...
UPDATE 1-US FDA OKs Erbitux to treat head and neck cancer Mar 1, 2006
Reuters WASHINGTON, March 1 (Reuters) - The US Food and Drug Administration on Wednesday approved Erbitux to treat head and neck cancer in cases when surgery is not an ...
Erbitux Approved to Treat Head and Neck Cancers Mar 3, 2006
Forbes FRIDAY, March 3 (HealthDay News) -- The drug Erbitux (cetuximab) has been approved to treat cancers of the head and neck, the US Food and Drug Administration ...
FDA Approves ERBITUX(R) (Cetuximab) for Treatment of Head and Neck ... Mar 1, 2006
Genetic Engineering News, NASDAQ: IMCL) and Bristol-Myers Squibb Company (NYSE: BMY) announced today that the US Food and Drug Administration (FDA) has approved ERBITUX(R) (Cetuximab ...
FDA Approves ERBITUX(R) (Cetuximab) for Treatment of Head and Neck ... Mar 2, 2006
International News Service, ImClone Systems Incorporated and Bristol-Myers Squibb Company announced today that the US Food and Drug Administration (FDA) has approved ERBITUX(R) (Cetuximab ...
FDA Approves ERBITUX(R) (Cetuximab) for Treatment of Head and Neck ... Mar 1, 2006
Finanzen.net, NASDAQ: IMCL) andBristol-Myers Squibb Company (NYSE: BMY) announced today that the USFood and Drug Administration (FDA) has approved ERBITUX(R)(Cetuximab), an ...
MultiVu Video Feed: FDA Approves ERBITUX(R) (Cetuximab) for ... Mar 1, 2006
Finanzen.net, Today, the US Food and Drug Administration (FDA) approved ERBITUX(R) (Cetuximab) in combination with radiation therapy for the treatment of a certain type of ...
FDA Approves Erbitux For Treatment Of Head And Neck Cancer Mar 2, 2006
Playfuls.com, The US Food and Drug Administration (FDA) approved Erbitux (Cetuximab) in combination with radiation therapy for the treatment of a certain type of locally or ...
FDA Approves Erbitux To Treat Head And Neck Cancer Mar 2, 2006
All Headline News ...(AHN) - The US Food and Drug Administration approves Erbitux (cetuximab) for use in combination with radiation therapy to treat patients with squamous cell ...
FDA Approves Erbitux for Squamous Cell Head-and-Neck Cancer Mar 2, 2006
MedPage Today, ROCKVILLE, March 2 - The FDA has approved Erbitux (cetuximab) for treatment of advanced squamous cell cancer of the head and neck. ...
Erbitux approved for head and neck cancer in US Mar 3, 2006
Pharmaceutical Business Review The FDA has approved ImClone Systems and Bristol-Myers Squibb's Erbitux, an IgG1 monoclonal antibody, for use in the treatment of squamous cell carcinoma of ...
Erbitux Approved for Head and Neck Cancers Mar 2, 2006
Cancerpage.com, By Rachael Myers Lowe, cancerpage.com. ( March 1, 2006 ) – The FDA has approved the drug Erbitux (cetuximab) for use in head and neck cancer. ...
Erbitux gets federal OK as first head-and-neck cancer drug since ... Mar 1, 2006
SouthCoastToday.com, By THE ASSOCIATED PRESS. WASHINGTON — Federal regulators yesterday approved Erbitux as the first new drug to treat head and neck cancer since the 1950s. ...
FDA OKs Erbitux for other cancers Mar 3, 2006
Albuquerque Tribune, By Associated Press. WASHINGTON - Federal regulators have approved Erbitux as the first new drug to treat head and neck cancer since the 1950s. ...
Erbitux Now Approved for Head and Neck Cancers Mar 3, 2006
ACS News Center, The US Food and Drug Administration has approved the drug Erbitux (cetuximab) for certain patients with cancers of the head and neck. ...
FDA OKs expanded Erbitux treatments Mar 1, 2006
CNN/Money WASHINGTON (Reuters) - The Food and Drug Administration Wednesday approved Erbitux to treat head and neck cancer in cases when surgery is not an option or ...
Erbitux Approved to Treat Head and Neck Cancers Mar 2, 2006
HealthCentral.com The drug Erbitux has been approved to treat head and neck cancer, according to the US Food and Drug Administration. The drug, which ...
FDA approves Erbitux Mar 13, 2006
myDNA.com, The Food and Drug Administration (FDA) has announced the approval of Erbitux (cetuximab) for use in combination with radiation therapy to treat patients with ...
ImClone’s Erbitux Receives FDA Label In Head And Neck Cancer Mar 2, 2006
BioWorld Online (subscription), ...to get a $250 million milestone payment from partner Bristol-Myers Squibb Co., thanks to the FDA’s approval of the colorectal cancer drug Erbitux for the ...
New Erbitux approval to head off cancer Mar 6, 2006
In-PharmaTechnologist.com, 06/03/2006 - Last week’s approval of Erbitux in the US breaks a 30-year drought in treatments for head and neck cancer, a disease that kills 11,000 people in ...
April 2006 Clinical Briefs Mar 28, 2006
U.S. Medicine, The Food and Drug Administration (FDA) last month announced the approval of Erbitux (cetuximab) for use in combination with radiation therapy to treat patients ...
FDA Approves ERBITUX(R) (Cetuximab) for Treatment of Head and Neck ... Mar 1, 2006
Yahoo! News (press release) News) and Bristol-Myers Squibb Company (NYSE: BMY - News) announced today that the US Food and Drug Administration (FDA) has approved ERBITUX® (Cetuximab), an ...
FDA Approves Erbitux® For Treatment of Head and Neck Cancer Mar 2, 2006
Cancer Consultants (press release), The United States Food and Drug Administration (FDA) has approved the monoclonal antibody Erbitux® (cetuximab) for the treatment of head and neck cancer. ...
Erbitux gets US green light for head and neck cancer Mar 2, 2006
Pharma Times (subscription), ImClone Systems and Bristol-Myers Squibb won approval in the USA yesterday to expand the indications of their colorectal cancer drug Erbitux to include the ...
Addition of Erbitux® to Chemotherapy Promising as Initial ... Mar 7, 2006
Cancer Consultants (press release), According to results recently published in the Annals of Oncology, the addition of Erbitux® (cetuximab) to the chemotherapy combination consisting of Camptosar ...
Woman expects to spend $80K for US cancer drug Mar 29, 2006
Winnipeg Free Press (subscription), Last week, Kjartanson got her first treatment of Erbitux at a Mayo Clinic. ... Erbitux and Avastin are among the new treatments that have not even made that list. ...
Lifestyle and the rise in head and neck cancers Mar 31, 2006
Times Online, Last week a number of experts, including Peter Rhys-Evans, of the Royal Marsden, who looked after John, talked in Amsterdam about Erbitux (cetuximab) in the ...
US FDA OKs Erbitux to treat head and neck cancer Mar 1, 2006
Reuters ...on Wednesday approved ImClone (IMCL.O: Quote, Profile, Research) and Bristol-Myers Squibb Co's (BMY.N: Quote, Profile, Research) drug Erbitux to treat head and ...
FDA Approves Erbitux (Cetuximab), First Head & Neck Cancer ... Mar 2, 2006
DG News BETHESDA, MD -- March 2, 2006 -- The Food and Drug Administration (FDA) today announced the approval of Erbitux (cetuximab) for use in combination with ...
Erbitux receives federal approval as first new head and neck ... Mar 1, 2006
Pravda, US government regulators Wednesday approved Erbitux as the first new drug to treat head and neck cancer since the 1950s. The Food ...
Erbitux Approved for Treatment of Head and Neck Cancer Mar 3, 2006
Daily News Central, The FDA said it approved the new use for the drug based on a study that showed Erbitux, in combination with radiation therapy, prolonged the lives of head and ...
Erbitux® Plus Chemotherapy and Radiation Therapy Promising in ... Mar 2, 2006
Cancer Consultants (press release), According to results recently published in the Journal of Clinical Oncology, the combination of Erbitux® (cetuximab) plus chemotherapy and radiation therapy ...
Schering defeat seen forcing German Merck to act Mar 27, 2006
Reuters ..."It would give them a multiple sclerosis franchise, and access to manufacturing facilities for biologics that could help cut costs of making Erbitux," he said. ...
Britain: Breast cancer patient’s legal challenge highlights ... Mar 30, 2006
World Socialist Web Site, Other cancer-fighting drugs such as Avastin, Erbitux, Gleevec, Rituxan and Tarceva are also increasingly deemed too expensive and are not currently widely ...
CFD Therapeutics Formed to Advance Monoclonal Antibodies for ... Mar 31, 2006
GenomicsProteomics.com (press release), ...greater cancer and tissue specificity than well-known therapeutic targets such as HER-2 and EGF-R, the target antigens for Herceptin ® and Erbitux ® .". ...
FDA gives greenlight for new treatment of head and neck cancer Mar 4, 2006
News-Medical.net, The US Food and Drug Administration has approved colon cancer drug Erbitux to treat head and neck cancer after results of a large clinical trial showed the ...
FDA Approves First Head & Neck Cancer Treatment in 45 Years Mar 10, 2006
Rocklin and Roseville Today, The Food and Drug Administration (FDA) announced the approval of Erbitux (cetuximab) for use in combination with radiation therapy to treat patients with ...
(PRN) Recent FDA Action Validates ADVEXIN(R) Registration Strategy ... Mar 3, 2006
Houston Chronicle, Erbitux(R) (Centuximab) is marketed by Bristol-Myers Squibb and was approved for use as monotherapy in recurrent head and neck cancer patients on the basis of ...
Distribute a news release with PR Mar 5, 2006
Opinion Journal, The first story concerns Erbitux, the ImClone cancer drug that became infamous after its initial rejection by the Food and Drug Administration in December 2001 ...
FDA approves new drug for head & neck cancer Mar 3, 2006
Cancerfacts.com, The drug, cetuximab, marketed as ERBITUX® by ImClone Systems and Bristol-Myers Squibb is a new generation drug that specifically targets a protein regulating ...
Hana Paying Up To $42M For Inex’s Cancer Drugs Mar 17, 2006
BioWorld Online (subscription), Ahn compared Marqibo to Erbitux (cetuximab), the colorectal cancer drug from ImClone Systems Inc. and Bristol-Myers Squibb Co., both of New York. ...
Cancer drugs can top $100,000 a year Mar 19, 2006
Chicago Sun-Times, Take Erbitux, approved for advanced colorectal and head-and-neck cancers. ... ERBITUX (Colorectal and head-and-neck cancers): $9,800 per month. ...
FDA Approves First Head & Neck Cancer Treatment in 45 Years Mar 2, 2006
Kansas City infoZine, Washington, DC - infoZine - The Food and Drug Administration (FDA) yesterday announced the approval of Erbitux (cetuximab) for use in combination with ...
Schwarz Pharma Surges 10% on Takeover Speculation (Update1) Mar 29, 2006
Bloomberg Merck, which sells colon cancer drug Erbitux in Europe, had sought to acquire Schering to expand its branded drugs division and become one of Germany's largest ...
An Alternative For Cancer Patients Mar 29, 2006
BusinessWeek Patterson, 50, returns to the facility once a month for an infusion of chemotherapy drug Erbitux and a checkup. She still has end-stage cancer. ...
Insider lawsuit is familiar Mar 30, 2006
San Francisco Chronicle, 2001, the ImClone founder allegedly told his daughter and father that the FDA was going to turn down an application to approve the company's main drug, Erbitux ...
Highmark, UPMC team up to improve access to expensive cancer ... Mar 28, 2006
Pittsburgh Post Gazette, With names such as Avastin and Erbitux, the new treatments for various cancers and leukemias can require annual spending of anywhere from $10,000 to $70,000 ...
��：生命�纬 Mar 1, 2006
BioX, WASHINGTON/NEW YORK (Reuters) - US regulators on Wednesday approved ImClone Systems Inc.'s (Nasdaq:IMCL - news) colon cancer drug Erbitux to treat head and ...
City & Corporate: Merck KGaA Drafts in FD to Handle Schering Bid Mar 17, 2006
International News Service, Merck, the German drug company behind colorectal cancer drug Erbitux, announced its EUR14.6bn (pounds 10.1bn) bid for Schering on Monday, a day after Schering ...
VHI premiums jump by two-thirds in five years Mar 23, 2006
IrishExaminer.com, ...covered. This includes drugs such as Erbitux and Avastin, used to fight colo-rectal cancer, which can cost up to €12,255 per patient. ...
Newspapers Examine Prescription Drug Cost Issues Mar 21, 2006
Kaiser network.org, For example, Erbitux, a treatment for advanced colorectal and head-and-neck cancers, costs about $9,800 monthly, while Avastin, a colorectal cancer treatment ...
Head, neck cancer drug in Martha Stewart trial gets federal OK Mar 1, 2006
Newsday, WASHINGTON (AP) _ Federal regulators on Wednesday approved Erbitux, the drug at the center of the Martha Stewart stock scandal, as the first new drug to treat ...
ImClone shares fall after expected drug approval Mar 2, 2006
Reuters 3 percent on Thursday, a day after the biotechnology company received a widely expected additional approval to expand its colon cancer drug Erbitux to treat ...
FDA OKs Drug for Head & Neck Cancer Mar 2, 2006
WebMD March 2, 2006 -- The FDA has approved Erbitux, a drug to help treat cancer of the head and neck. Erbitux is designed for use in ...
Policy on breakthrough treatments labelled unethical Mar 6, 2006
Winnipeg Free Press (subscription), Darlene Kjartanson, a teacher assistant in Ile des Chenes, has driven to Arizona with her husband Terry in hopes of paying out of pocket for Erbitux.They are ...
Im Clone Scandal Free And Developing New Treatments Mar 2, 2006
All Headline News The US Food and Drug Administration (FDA) has approved ERBITUX(R) (Cetuximab), for the treatment of squamous cell carcinoma of the head and neck and is the ...
FDA approves new drug to treat head-and-neck cancer Mar 1, 2006
WBNS, The Food and Drug Administration says Erbitux (UR'-bih-tuks) may now be used to treat squamous cell cancer of the head and neck that cannot be removed by ...
Compiled from wire reports Mar 2, 2006
Newsday, IMCLONE WINS US OK FOR ERBITUX. ImClone Systems Inc. won US approval to sell its Erbitux colon cancer medicine to treat patients ...
New Drug For Head & Neck Cancer Mar 2, 2006
KOLD-TV, The Food and Drug Administration has given its approval to the drug Erbitux for the treatment of squamous cell cancer of the head and neck that can't be ...
Bristol-Myers Squibb Plans to Build Biologics Facility in the US Mar 8, 2006
Finanzen.net, Mr. Hooper will also update investors on ERBITUX(R), which it co-markets with ImClone Systems Incorporated. On March 1, ERBITUX ...
Patients, MDs Should Have 'Autonomy' in Treatment Decisions ... Mar 6, 2006
Kaiser network.org, ...to the editorial, "We now know that the FDA could have extended a lot of lives had it followed that principle with" the cancer medication Erbitux "from the ...
Heart disease, cancer deaths down Mar 26, 2006
Chicago Sun-Times, Other new cancer drugs are even more expensive. Erbitux, approved for colorectal and head-and-neck cancers, costs $9,800 a month. ...
First cancer drug in 45 years approved Mar 15, 2006
Boca Raton News, The Food and Drug Administration (FDA) has announced approval of Erbitux (cetuximab) -- the first new drug in the last 45 years approved for the treatment of ...
Two New Cancer Drugs Discovered Mar 28, 2006
Medical News Today (press release), Epidermal Growth Factor Receptors (EGFR), which are targeted by other successful agents such as trastuzamab (Herceptin), cetuximab (Erbitux) and gefitinib ...
Merck of Germany Expected to Seek Control of Schering Mar 12, 2006
New York Times, The German Merck produces the cancer drug Erbitux as well as generic drugs, chemicals like paint pigments and liquid-crystal displays used in television. ...
Merck makes €15bln hostile bid for Schering Mar 13, 2006
RTE.ie, Merck specialises in generic drugs and cancer treatments such as its Erbitux drug and Schering, fertility drugs, and also makes the MS drug Betaferon. ...
The Four Major Cancer Markets, Which Include Colorectal, Prostate ... Mar 2, 2006
Genetic Engineering News, Continued uptake of Tarceva and potential approvals for Avastin, Zactima, Erbitux and other new therapies will offset the decline in value that has come as a ...
Drug approved to treat head, neck cancer Mar 1, 2006
Austin American-Statesman (subscription), WASHINGTON — Federal regulators Wednesday approved Erbitux as the first new drug to treat head and neck cancer since the 1950s. ...
Ardana appoints Klaus Falk as VP Sales & Marketing Mar 17, 2006
PharmaLive.com (press release), Europe, he was responsible for Sales & Marketing and his achievements included the successful launch of the oncology franchise's first product, Erbitux, in 2003 ...
New Therapies Target Cancer Mar 7, 2006
Drug Discovery & Development (subscription), Erbitux (cetuximab) was the first approved for patients with advanced colorectal cancer that has spread to other parts of the body. ...
Ardana brings in sales heavyweight with eye on second launch Mar 17, 2006
Scotsman, As European vice-president, he was responsible for sales and marketing and duties for the launch of the oncology franchise's first product, Erbitux, in 2003. ...
MAb Causes Reactions In Phase I; Six In Hospital Mar 21, 2006
BioWorld Online (subscription), ...was Orthoclone (Johnson & Johnson) in 1986 for allograft rejection, and one of the most recent approvals, in February 2004, went to Erbitux, ImClone Systems Inc ...
Research and Markets: The FDA is Encouraging the Use of Biomarkers ... Mar 22, 2006
PharmaLive.com (press release), ...targeted oncology drugs, including trastuzumab (Genentech's Herceptin), imatinib mesylate (Novartis's Gleevec), and cetuximab (ImClone's Erbitux), are already ...
CytoDyn Welcomes Dr. Trevor Hawkins to Its Scientific Advisory ... Mar 3, 2006
Financial News USA (press release), ...and Bristol-Myers Squibb Company (NYSE: BMY) announced recently that the US Food and Drug Administration (FDA) has approved ERBITUX® (Cetuximab), an IgG1 ...
Merck KGaA Announces Takeover Offer for Schering AG Mar 13, 2006
PharmaLive.com (press release), ...bring together two very complementary oncology businesses with significant near-term growth potential driven by Merck’s highly successful Erbitux® franchise ...
Schering says German rival Merck plans bid Mar 12, 2006
Scotsman, ...crystals that go into flat screens and mobile phone displays, it has a strong generic drugs division and sets great store by new colo-rectal cancer drug Erbitux ...
Schering CEO says bid undervalues the company Mar 13, 2006
MarketWatch Yasmin. It also sells multiple-sclerosis drug Betaferon. Merck's best-known drug is Erbitux, for colorectal cancer. Merck called ...
Schering Shares Soar on Merck Buyout Offer Mar 13, 2006
CBS News ...billion). Sales of its leading cancer drug, Erbitux, accounted for 218 million euros ($259.8 million), up from 77 million euros. ...
Schering Shares Up 22 Pct. on Buyout Offer Mar 13, 2006
Houston Chronicle, ...billion). Sales of its leading cancer drug, Erbitux, accounted for euro218 million ($259.8 million), up from euro77 million. Schering ...
Schering Rejects Merck Offer Mar 13, 2006
Red Herring, Merck is controlled by the Merck family, which own 73 percent of the company’s stock, and produces the cancer treatment Erbitux, in partnership with ImClone ...
Update 4: Schering Shares Soar on Merck Buyout Offer Mar 13, 2006
Forbes Merck's best known drug is the cancer fighting Erbitux, which it sells internationally for its partner, New York-based ImClone Systems Inc. ...
Merck KGaA sees little resistance to Schering bid from large ... Mar 13, 2006
Forbes Merck wants to use Schering's sales force to help market its cancer drug Erbitux, as well take advantage of Schering's know-how in marketing central nervous ...
US Stock-Index Futures Fall; Dana, DuPont Decline in Europe Mar 2, 2006
Bloomberg The biotechnology company won approval from the US Food and Drug Administration for its Erbitux colon-cancer drug for use against head and neck tumors, the ...
snub fires up European drug giants Mar 13, 2006
Telegraph.co.uk, However, Merck - whose best-known drug is the cancer treatment Erbitux, which it sells internationally for its partner, New York-based ImClone Systems ...
German drugs firm snubs £10bn offer Mar 13, 2006
Guardian Unlimited, But Michael Mecker, finance director at Merck, which makes Erbitux for combating colo-rectal cancer as well as liquid crystals for flat screens and mobile ...
Stock Futures Lower on Retail Data Mar 2, 2006
Forbes ...and Bristol-Myers Squibb Co. said late Wednesday the Food and Drug Administration has approved Erbitux for use in the treatment of cancer in the head and neck. ...
Mazuz draws fire for postponing drug basket expansion Mar 16, 2006
Jerusalem Post, Among the drugs proposed for the basket are Erbitux, the very expensive colon cancer drug, and the preventive use of Herceptin to reduce the risk of a return ...
German Pharma Powerhouse Potential Mar 13, 2006
BusinessWeek The deal would create a much stronger player in oncology. Merck's colorectal-cancer drug Erbitux was recently approved to treat head and neck cancer. ...
UC doctors study drug's effect on cancer progression 21 Dec 2005
Cincinnati Business Courier, Led by Dr. Rami Komrokji, director of UC's leukemia and lymphoma unit, the study will test the effectiveness of cetuximab (Erbitux), a targeted (monoclonal ...
Zacks.com announces that Nadine Wong highlights: Abgenix and Amgen 21 Dec 2005
Business Wire (press release), ...me too" drug. Panitumumab will compete against ImClone/Bristol-Myer's Erbitux with dosing convenience, biweekly vs. once weekly ...
New Products and Line Extensions are the Contributing Factors to ... 21 Dec 2005
New Age Media Concepts (press release) Continued uptake of Tarceva and potential approvals for Avastin, Zactima, Erbitux and other new therapies will offset the decline in value that has come as a ...
Erbitux® Plus Gemzar®/Paraplatin® Promising for Stage IV NSCLC Dec 19, 2005
Cancer Consultants (press release), According to a recent article published in the Journal of Clinical Oncology, the treatment combination consisting of Erbitux (cetuximab) plus Gemzar ...
Latest Data on Marked Survival Improvement with Erbitux® in Head ... Nov 22, 2005
Cancer Consultants (press release), ...recently presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, the addition of Erbitux® (cetuximab) to ...
Blockbuster Drugs Rituxan, Avastin, and Erbitux Changes the Way ... Dec 5, 2005
Genetic Engineering News, The blockbuster drugs Rituxan, Avastin, and Erbitux have changed the way the industry looks upon antibody treatment of cancer in the same way that Taxol ...
New Product Launches in the Cancer Market such as Erbitux, Avastin ... Nov 21, 2005
Business Wire (press release), DUBLIN, Ireland--(BUSINESS WIRE)--Nov. 21, 2005--Research and Markets (http://www.researchandmarkets.com/reports/c28122) has announced ...
New Product Launches in the Cancer Market such as Erbitux, Avastin ... Nov 21, 2005
PharmaLive.com (press release), DUBLIN, Ireland--(BUSINESS WIRE)--Nov 21, 2005 - Research and Markets (http://www.researchandmarkets.com/reports/c28122) has announced the addition of The ...
Amgen Buys Abgenix for $2.2B Dec 15, 2005
Red Herring, That puts substantial pressure on ImClone Systems, another biotech company that has been developing a colon cancer drug, Erbitux (see Erbitux’s Next Round). ...
Amgen Buys Abgenix for $2.2B Dec 16, 2005
Red Herring, That puts substantial pressure on ImClone Systems, another biotech company that has been developing a colon cancer drug, Erbitux, which it markets with Bristol ...
Amgen Avoids Profit Sharing, Buys Abgenix Dec 14, 2005
Forbes The drug is expected to compete with Erbitux, a drug co-marketed by ImClone Systems (nasdaq: IMCL - news - people ) and Bristol-Myers Squibb (nyse: BMY - news ...
Amgen to Acquire Abgenix for $2.2 Billion in Cash (Update2) Dec 14, 2005
Bloomberg ...and Bristol-Myer Squibb Co.'s Erbitux colon cancer drug, Orbimed's Borho said. ``They're going head-to-head with Erbitux,'' Borho said. ...
Amgen Keeps the Profit Dec 16, 2005
Motley Fool When marketed, panitumumab will compete against Erbitux, a monoclonal antibody developed by ImClone Systems (Nasdaq: IMCL) and marketed by Bristol-Myers Squibb ...
Amgen to Buy Abgenix, Getting Complete Control of New Colon Cancer ... Dec 14, 2005
New York Times, But panitumumab is quite similar to Erbitux, a drug already sold jointly by ImClone Systems and Bristol-Myers Squibb. Amgen maintains ...
Amgen to Buy Drug Firm Dec 15, 2005
Los Angeles Times, ...options. The drug would compete with Erbitux, a cancer medicine marketed by ImClone Systems Inc. and Bristol Myers-Squibb Co. Investors ...
UPDATE: Amgen To Buy Abgenix For $2.2 Bln Dec 14, 2005
Business Online, That news could spell trouble for rival ImClone (IMCL), whose antibody-based drug Erbitux is also approved to treat colorectal cancer in patients who have ...
Amgen to buy Abgenix Dec 14, 2005
Providence Journal (subscription), ...said. "They're going head-to-head with Erbitux," Borho said. "With Amgen's marketing, it could become a bigger drug than Erbitux.". ...
Amgen buys Abgenix to secure cancer drug rights Dec 15, 2005
Pharma Times (subscription), ...is a fully-human antibody that inhibits the epidermal growth factor receptor (EGFr), so is similar in action to ImClone System's Erbitux (cetuximab), sold by ...
Imclone Systems shares down on report Dec 5, 2005
BusinessWeek ...slipped Monday after one analyst predicted that a competing cancer treatment may usurp US market share from Erbitux in the next three to four years. ...
Amgen agrees to spend $2.2bn cash for Abgenix Dec 14, 2005
MSN Money It could compete with Erbitux, by ImClone and Bristol-Myers Squibb, and has the potential to be the first epidermal growth factor inhibitor to treat cancer and ...
Aftermarket Movers: Amgen, Abgenix jump Dec 14, 2005
BusinessWeek Amgen and Abgenix were already collaborating on a cancer drug that, if approved by regulators, would compete with Imclone's Erbitux, currently the only drug of ...
Labor court orders HMO to pay for anti-cancer drug Dec 6, 2005
Ha'aretz (subscription), Meuhedet had refused to provide Amram Miller with Erbitux, a drug that prevents cancer from spreading in cases that do not respond to chemotherapy. ...
ImClone Shares Could See 25% Downside Dec 7, 2005
Forbes The great majority of ImClone's value is derived from Erbitux, a cancer drug marketed by Bristol-Myers Squibb (nyse: BMY - news - people ). ... |
